


Harold D.
Efficient and easy
In stock · arrives 2 to 4 working days after payment
Pay by card or PayPal (confirmed instantly), Instant EFT, EFT or crypto
Damaged or wrong? We replace or refund
Packed and shipped from Cape Town, South Africa. Dispatched within 24 to 36 hours, then tracked courier (Aramex or The Courier Guy) to your door in 1 to 3 working days.
ARA-290, also called cibinetide, is a synthetic peptide of eleven amino acids whose sequence is drawn from a structural region of the erythropoietin molecule. Unlike erythropoietin itself, it is described in the published literature as non-erythropoietic. AP supplies it as a research material only.
The bulk of it is preclinical — rodent models and cell-based assays, often concerned with receptor interaction and inflammatory signalling. The overall body of literature is small next to older, more heavily studied peptides, so it is worth working from the primary papers rather than secondary summaries.
The short version: ARA-290, now named cibinetide, is an 11-amino-acid peptide derived from erythropoietin (EPO) and designed not to raise red blood cell production. It reached small phase 2 trials for nerve pain in sarcoidosis and was never approved.
EPO is the hormone best known for telling the body to make red blood cells. It also has a tissue-protecting side, which runs through a different receptor that researchers call the innate repair receptor. ARA-290 is a short, 11-amino-acid peptide derived from EPO and engineered to act on that repair receptor without stimulating red blood cell production. Its developer was Araim Pharmaceuticals, a US company.
The target was small-fibre neuropathy in sarcoidosis, where damage to the thinnest nerve fibres causes nerve pain and problems with automatic body functions. Two small phase 2 trials led from Leiden University Medical Center in the Netherlands reported better neuropathy symptom scores, more nerve fibres in the cornea (the clear front of the eye), and improved quality of life and physical function.
A larger phase 2b trial followed, published in Investigative Ophthalmology and Visual Science in 2017 (Culver and colleagues). It randomised 64 people for 28 days. The main measure, corneal nerve fibre area, rose significantly against placebo in only one of the three dose groups. Pain scores fell in every group, placebo included.
The European Commission granted cibinetide orphan designation for sarcoidosis in October 2013. That status recognises a rare disease target. It is not an approval.
Every trial was small and lasted about a month, and several of the authors worked for Araim. We found no phase 3 results, and no regulator has approved it for any use. Corneal nerve counts are a stand-in measure; whether they translate into lasting relief was never settled.
It arrives as a freeze-dried powder. Once bacteriostatic water goes in, it belongs in the fridge. Our reconstitution and storage guide covers the details, and the calculator does the maths.
A clever piece of EPO engineering with encouraging small trials, which stopped short of the large one that would have settled it.
For research use only. Not for human consumption. Nothing on this page is medical advice.
No reviews from orders with ARA-290 yet. Here is what recent customers said about ordering from us.
★★★★★
Efficient and easy
Harold D. · 18 Nov 2026
★★★★★
I went on holiday and stressed that I would not get my research materials in time, but you and the delivery company did not disappoint! Thank you for excellent pre order advice on products, user friendly ordering system, and superb delivery system!!!
Nicoleen · 18 Nov 2026
★★★★★
You guys are the best. Prices are good and service is outstanding
Glenda S. · 17 Nov 2026
★ 4.9 across all 117 AP reviews, good and bad. See them. Every reviewer gets R100 store credit, whatever they rate.
Follow my channel — every couple of weeks I drop one genuinely useful thing: how to read a COA, reconstitution math, the odd honest deal. No spam, no hype.
Follow Lab Notes on WhatsAppFree · follow & mute anytime · research use only. New here? WELCOME99 = R99 off a first order of R400 or more (doesn’t stack with sale discounts) →
Please read before entering this website.
All products offered on this website are strictly intended for scientific research and laboratory use only. They are not intended for human consumption, veterinary use, or any other purpose outside of controlled research environments.
These products have not been evaluated, approved, or certified by the South African Health Products Regulatory Authority (SAHPRA), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), or any other regulatory authority for use in humans or animals.
By entering this website you confirm that:
AP accepts no liability for misuse of any product sold on this platform.
Join our email list and we’ll put WELCOME99 on your basket now: R99 off a first order of R400 or more. You’ll get restock news and the odd offer. Unsubscribe any time.
One use per email, first order only. Doesn’t stack with sale discounts. Research use only.
It’s on your basket: R99 off your first order of R400 or more.
Go to checkoutWe only deliver in South Africa for now. Tell us where you are, and we’ll let you know if we start delivering there.
We only use this to tell you about delivery to your country.
We’re counting where people want delivery. The countries with the most interest come first.
Chats are read by the AP team to help you. Never share card details here. Prefer a person? WhatsApp us